Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc.

    Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc.

PR Newswire

SAN DIEGO, April 4, 2013

SAN DIEGO, April 4, 2013 /PRNewswire/ --Ajinomoto Co., Inc. ("Ajinomoto Co.";
TYO: 2802) and Althea Technologies, Inc. ("Althea Technologies"), have
completed the previously announced acquisition of Althea Technologies, a
leading provider of biopharmaceutical development and manufacturing services.

(Logo: http://photos.prnewswire.com/prnh/20121024/LA98976LOGO)

Ajinomoto acquired all the capital stock of Althea at closing for a purchase
price of approximately $175 million dollars (USD). Althea will become a fully
consolidated subsidiary of Ajinomoto Co., Inc. operating under the company
name Ajinomoto Althea, Inc.

About Ajinomoto Co.
Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed
foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For
many decades Ajinomoto Co. has contributed to food culture and human health
through wide-ranging application of amino acid technologies. Today, the
company is becoming increasingly involved with solutions for improved food
resources, human health and global sustainability. Founded in 1909 and now
operating in 26 countries, Ajinomoto Co. had net sales of JYP 1,197.3 billion
(USD 15.1 billion) in fiscal 2011. For more about Ajinomoto Co. (TYO: 2802),
visit www.ajinomoto.com.

About Althea Technologies
Althea Technologies is a fully integrated, contract development and
manufacturing organization located in San Diego, CA providing clinical and
commercial product development services. Althea Technologies offers cGMP drug
product filling in both vials and syringes, and production of
microbial-derived recombinant proteins and plasmid DNA. In conjunction with
these manufacturing operations, Althea Technologies offers comprehensive
development services including: upstream and downstream process development,
analytical development, lyophilization cycle, complex formulation, product
release and ICH-compliant stability testing. Althea Technologies' formulation
technology platform includes Crystalomics®, a proprietary technology that
offers a formulation solution for large molecule products that must be
delivered at high concentrations or as sustained release formulations. For
more information, visit www.altheatech.com.

SOURCE Ajinomoto Althea, Inc.

Website: http://www.ajinomoto.com
Contact: Althea Technologies, Inc., Tristen Welch, Marketing Strategist, (858)
882-0220 x535, twelch@altheatech.com
Press spacebar to pause and continue. Press esc to stop.